<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
CNSP
CNS Pharmaceuticals
$
()


  • CNS Pharmaceuticals prices $4.0M public offering at 30c per share

    1/29/2024 - 21:33pm
  • CNS Pharmaceuticals appoints Amy Mahery to board of directors

    1/18/2024 - 08:47am
  • CNS Pharmaceuticals completes planned enrollment in study of berubicin in GBM

    1/17/2024 - 08:52am
  • CNS Pharmaceuticals says DSMB recommends continuation of berubicin trial

    12/18/2023 - 08:58am
  • CNS Pharmaceuticals files to sell 3.81M shares of common stock

    12/8/2023 - 17:31pm
  • CNS Pharmaceuticals presents updated safety data from berubicin study

    11/22/2023 - 09:09am
  • CNS Pharmaceuticals files to sell 3.76M shares of common stock for holders

    11/20/2023 - 17:28pm
  • CNS Pharmaceuticals expects cash to fund operations through 4Q23

    11/15/2023 - 08:51am
  • CNS Pharmaceuticals announces upcoming milestones

    11/15/2023 - 08:50am
  • CNS Pharmaceuticals reports Q3 EPS ($1.08) vs. ($2.56) last year

    11/15/2023 - 08:50am
  • CNS Pharmaceuticals enrolls 229 of expected 243 patients in berubicin study

    10/11/2023 - 08:48am
  • CNS Pharmaceuticals reaches enrollment of 200 patients in berubicin study

    9/7/2023 - 08:53am
  • CNS Pharmaceuticals presents updated results from berubicin study

    8/14/2023 - 09:17am
  • CNS Pharmaceuticals expects cash to fund operations into 4Q23

    8/14/2023 - 07:59am
  • CNS Pharmaceuticals reports Q2 EPS ($1.04) vs. ($2.67) last year

    8/14/2023 - 07:58am
dynamic_feed Breaking News